Clal Biotechnology Industries cbi.co.il


Clal Biotechnology Industries is a public investment firm targeting pre-clinical, seed, start-up, early venture, emerging growth and growth capital stages of financing that was founded in 1998 and based in Tel Aviv, Israel. Clal primarily invests in biopharmaceutical and biotech companies. Generally, Clal Biotechnogy Industries looks to invest up to $10 million per company and prefers to be lead investor and take a board seat. It also seeks to take a majority share in its portfolio companies.

Clal Biotechnology Industries is a public investment firm targeting pre-clinical, seed, start-up, early venture, emerging growth and growth capital stages of financing that was founded in 1998 and based in Tel Aviv, Israel. Clal primarily invests in ...Show all

Company (Alive / Active)

Phone: +972-3-6121616

Fax: (+9) 723-612-4545

Hogi Tower
12 Abba Hillel Silver St
Ramat Gan, 52506
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Clal Biotechnology Industries $0M Apr 5, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Clal Biotechnology Industries Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors

Board Members

Competitors

Company Status Description Investors

Orexigen Therapeutics

La Jolla, California, United States
Assets PurchasedOrexigen Therapeutics, based in San Diego, California, is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system (CNS), disorders, with an initial focus on obesity. The Company combines individual generic drugs that have previously received regulatory approval for other indications and, thus, have established post-marketing safety records. It screens these drugs for synergistic CNS activity and combines them into ne...Show allLogin to see details

Genicon Sciences Corporation

San Diego, California, United States
Alive / ActiveGenicon Sciences Corporation (Now part of Invitrogen) Genicon Sciences is a company providing assay solutions to the biotechnology, genomics, proteomics and clinical diagnostics industries. The company's Resonance Light Scattering (RLS) technology is a patented, ultra-sensitive signal generation platform for the simple and efficient detection, measurement and analysis of biological interactions. RLS technology aims to utilize the Resonance Light Scattering properties of nano-size particles that ...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)